热门资讯> 正文
Crystem Pharmaceuticals任命Tobin Schilke为首席财务官
2025-02-24 21:57
- Crinetics Pharmaceuticals (NASDAQ:CRNX) on Monday announced the appointment of Tobin Schilke as chief financial officer (CFO), effective February 28, 2025.
- Prior to joining Crinetics, Schilke served as CFO at Revance Therapeutics. Previously, Schilke served as CFO at Achaogen.
- The company expects to grant Schilke 52,000 restricted stock units (RSUs) and a stock option to purchase 80,000 shares of common stock.
- CRNX +1.44% premarket to $38.
- Source: Press Release
More on Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals: Attractive Speculative Bet On Market Weakness
- Crinetics upgraded to buy by Jefferies, atumelnant potential cited
- Crinetics falls after mid-stage trial data adrenal disorder therapy
- Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals
- Historical earnings data for Crinetics Pharmaceuticals
推荐文章
港股周报丨阿里重磅利好！周内暴涨14%；北水单周净买入港股608亿港元环比骤增8成
一周财经日历 | 万众瞩目！9月美联储利率决议来袭；三只港股新股即将上市
美股机会日报 | 金价年内或触及3800美元？国际大行集体唱多黄金！超微电脑涨超5%
能否赶上美联储下周议息会议？美参院就米兰理事提名表决时间定了
港股异动 | 重磅利好！阿里涨近7%，百度涨超6%
华盛早报 | 创近4年新高！阿里大涨8%；外资热情势不可挡！大摩：超九成美国投资者愿加仓中国资产
美股机会日报 | 美国8月CPI符合预期，初请失业金人数创近四年新高！“网红股”Opendoor股价大涨超30%
万亿南向“活水”疯狂抢筹！重仓阿里巴巴逾1200亿港元，如何抄“聪明钱”的作业？
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
